News

Filter

Current filters:

VertexJohnson & Johnson

Vertex links with Janssen and GlaxoSmithKline for combo trials with its VX-135 for hepatitis C

02-11-2012

US health care giant Johnson & Johnson's (NYSE: JNJ) Janssen Pharmaceuticals unit has entered into a…

Anti-viralsBiotechnologyGlaxoSmithKlineGSK2336805JanssenJohnson & JohnsonPharmaceuticalResearchsimeprevirVertexVX-135

Germany’s IQWiG sees added benefits for Incivo

24-01-2012

In an early benefit assessment pursuant to Germany’s Act on the Reform of the Market for Medicinal…

Anti-viralsEuropeIncivekIncivoJanssenJohnson & JohnsonPharmaceuticalPricingRegulationVertex

Johnson & Johnson’s telaprevir approved in Europe for genotype-1 chronic hepatitis C

21-09-2011

The European Commission has approved Johnson & Johnson (NYSE: JNJ) subsidiary Janssen’s Incivo (telaprevir),…

Anti-viralsEuropeIncivekIncivoJanssen PharmaceuticaJohnson & JohnsonPharmaceuticalRegulationtelaprivirVertex

Most US clinicians plan to prescribe Incivek and Victrelis for treatment-naive hep C patients

05-07-2011

More than two-thirds of surveyed US clinicians plan to prescribe Vertex/Johnson & Johnson/Mitsubishi…

Anti-viralsIncivekJohnson & JohnsonMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRocheVertexVictrelis

Opportunity in hepatitis C market for recently-approved Victrelis and Incivek; report

15-06-2011

Results from an on-line survey fielded just prior to the US Food and Drug Administration approval of…

Anti-viralsIncivekJohnson & JohnsonMarkets & MarketingMerck & CoPharmaceuticalVertexVictrelis

Merck & Co’s Victrelis and Vertex’ telaprivir get unanimous backing from FDA advisory panel for chronic hep C

29-04-2011

The Antiviral Drugs Advisory Committee of the US Food and Drug Administration has voted unanimously that…

Anti-viralsJohnson & JohnsonMerck & CoNorth AmericaPharmaceuticalRegulationtelaprivirVertexVictrelis

New findings with Vertex/J&J’s telaprevir bode well for hard to treat hepatitis C patients

12-04-2010

A study co-authored by a Saint Louis University, USA, researcher found telaprevir, a protease inhibitor…

Anti-viralsJohnson & JohnsonPharmaceuticalResearchtelaprivirVertex

COMPANY SPOTLIGHT

Menarini

Back to top